PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Nov-2022 Vertex Announces Partnership with Basketball Hall-of-Famer Alonzo Mourning to Raise Awareness of APOL1-Mediated Kidney Disease (AMKD) Businesswire
04-Nov-2022 Microcrystalline Cellulose Market Report 2022: New Grades of Microcrystalline Cellulose With Improved Pharmaceutical Characteristics Present Growth Opportunities - ResearchAndMarkets.com Businesswire
04-Nov-2022 Biomind Labs Announces Positive Initial Results From Its Phase II Trial on Its BMND01 Candidate for Treatment Resistant Depression Businesswire
04-Nov-2022 Anorexia Nervosa Market Surpassed USD 90 Mn in 2021, Impelled by Increasing Frequency of Dietary Diseases | insightSLICE insightSLICE
04-Nov-2022 Antiparasitic Drugs Global Market Report 2022: Government, Non-Profit and Market Player Initiatives to Boost Adoption Bode Well For Growth - ResearchAndMarkets.com Businesswire
04-Nov-2022 Global Non-steroidal Anti-inflammatory Drugs Market Report to 2027 - Players Include Merck & Co, Perrigo Company, Pfizer, Reckitt Benckiser and Sanofi - ResearchAndMarkets.com Businesswire
04-Nov-2022 Insights on the Throat Lozenges Global Market to 2027 - Development of Advanced Product Portfolios With Novel Formulations Presents Opportunities - ResearchAndMarkets.com Businesswire
04-Nov-2022 BeiGene to Present at Upcoming Investor Conferences Businesswire
04-Nov-2022 Bicycle Therapeutics to Participate in Upcoming Investor Conferences Businesswire
04-Nov-2022 Aphena’s Three-Year, $20M Tennessee Expansion Now Complete Businesswire
04-Nov-2022 Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine Businesswire
04-Nov-2022 Autolus Therapeutics to Present Three Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022 Autolus Therapeutics
04-Nov-2022 MiGenTra Highlights How Biosimilars Are Transforming Healthcare in Africa at the Festival of Biologics MiGenTra
04-Nov-2022 Immutep late-breaking abstract accepted for oral presentation on first-in-class LAG-3 therapeutic eftilagimod alpha at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting Immutep
04-Nov-2022 ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference ProQR
04-Nov-2022 Cherwell leading discussion on environmental monitoring and Annex 1 Cherwell
04-Nov-2022 Gloria Hunniford launches ‘Cuppa for Cancer Care’ campaign to promote local cancer treatment Cuppa for Cancer Care’
04-Nov-2022 BC Platforms Announces Partnership With CENTOGENE to Enable Access to Data-Driven Insights BC Platforms
04-Nov-2022 Transgene Announces Positive Interim Analysis Results of Phase II Trial Evaluating TG4001 + Avelumab vs Avelumab in HPV-Positive Anogenital Cancers Transgene
04-Nov-2022 Servier and OSE Immunotherapeutics announce completion of patient enrollment in the Phase 2a clinical trial of OSE-127/S95011 in primary Sjögren’s syndrome Servier and OSE